Betty Soliven to Myasthenia Gravis
This is a "connection" page, showing publications Betty Soliven has written about Myasthenia Gravis.
Connection Strength
2.286
-
Modulation of immune responses by bile acid receptor agonists in myasthenia gravis. J Neuroimmunol. 2020 12 15; 349:577397.
Score: 0.613
-
Impaired regulatory B cells in myasthenia gravis. J Neuroimmunol. 2016 08 15; 297:38-45.
Score: 0.453
-
Terbutaline in myasthenia gravis: a pilot study. J Neurol Sci. 2009 Feb 15; 277(1-2):150-4.
Score: 0.269
-
A Distinct Immunological Signature in Late-Onset Myasthenia Gravis: Insights from an Exploratory Proteomics Study. Ann Neurol. 2026 01; 99(1):198-210.
Score: 0.216
-
Postoperative Complications of Thymectomy in Myasthenia Gravis: Does Steroid Use Play a Role? Ann Thorac Surg. 2023 06; 115(6):1558.
Score: 0.175
-
ATM mutation in a patient with thymoma-associated myasthenia gravis. Muscle Nerve. 2020 08; 62(2):E50-E52.
Score: 0.150
-
Myasthenia gravis induced by avelumab. Immunotherapy. 2019 10; 11(14):1181-1185.
Score: 0.142
-
Head-drop: A frequent feature of late-onset myasthenia gravis. Muscle Nerve. 2017 09; 56(3):441-444.
Score: 0.120
-
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leuk Lymphoma. 2012 Mar; 53(3):371-80.
Score: 0.082
-
Seronegative myasthenia gravis. Neurology. 1988 Apr; 38(4):514-7.
Score: 0.065